Animal Antibiotics & Antimicrobials Market by Product, Mode of Delivery, Form, Type of Animal

Description

List of Tables

[190 Pages Report] The Animal Antibiotics & Antimicrobials Market size was estimated at USD 635.51 million in 2023 and expected to reach USD 667.23 million in 2024, at a CAGR 5.25% to reach USD 909.84 million by 2030.

Animal antibiotics & antimicrobials include substances used to treat and prevent bacterial infections in animals, promoting their health and welfare. The rising global demand for animal protein, driven by changing dietary patterns, is driving the market. The intensification of animal farming and increased awareness of the importance of preventing diseases in livestock contribute to the growing usage of antibiotics. Additionally, advancements in veterinary healthcare and a focus on improving overall animal productivity further propel the demand for antibiotics & antimicrobials in the animal health sector. Concerns over antimicrobial resistance (AMR) pose a significant challenge, as the overuse of antibiotics can lead to the development of resistant strains of bacteria. Regulatory restrictions and a push towards more sustainable farming practices contribute to the restraint on the use of certain antibiotics in animal agriculture. The growing trend toward the development of alternatives to traditional antibiotics, such as probiotics and phytogenics, presents an opportunity for innovation in the animal health sector. Furthermore, increased focus on preventive measures, such as vaccines and biosecurity practices, offers opportunities for sustainable growth in the animal antibiotics & antimicrobials market.

KEY MARKET STATISTICS
Base Year [2023]	USD 635.51 million
Estimated Year [2024]	USD 667.23 million
Forecast Year [2030]	USD 909.84 million
CAGR (%)	5.25%

Product: Growing need for antibiotics for disease prevention and treatment

Antibiotics present a significant component in animal healthcare, deployed for a myriad of purposes, including disease prevention, treatment, and growth promotion. The most commonly used antibiotics in the animal health sector are tetracyclines, penicillins, sulfonamides, and macrolides. Antimicrobials are agents that destroy or inhibit the growth of microorganisms in animals. These include antibiotics, antifungals, antiprotozoals, and antivirals. Their application spans various segments, including dairy, poultry, swine, and aquaculture, to ensure the health and welfare of animals and to mitigate the impacts of infectious diseases.

Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure

Injection is a common and effective method of drug delivery in veterinary medicine due to its streamlined administration and direct absorption into the bloodstream. This mode of delivery bypasses the digestive barriers and often results in a faster onset of medical action. Antibiotics such as penicillin, amoxicillin, and antivirals such as oseltamivir phosphate are often administered via injections for targeted, immediate relief. Oral delivery of antibiotics & antimicrobials for animals is the most non-invasive and convenient mode of delivery. Its main advantage lies in its ease of administration, particularly suitable for small scale farmers or pet owners with minimal medical proficiency.

Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections

Powders & tablets are common solid dosage forms for animal antibiotics and antimicrobials. They have gained traction due to their optimal stability, cost-effectiveness, and the potential for precision dosing. They are administered orally in drinking water or feed, making them a convenient option for veterinary use. Antimicrobial solutions are typically provided through allied routes, including oral, intramammary, or parenteral administration. They cater to a broad spectrum of bacterial infections and provide instant relief and rapid absorption. Solutions can be easily modified in terms of dosage, facilitating personalized treatment plans based on varying animal needs.

Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections

Companion animals including cats are prone to various bacterial infections, which manifest in different forms of diseases such as urinary tract infection and cat-scratch disease. Antibiotics such as amoxicillin and doxycycline are commonly used for their broad-spectrum antimicrobial properties. Veterinarians often prescribe antibiotics including enrofloxacin and amoxicillin for bacterial infections in dogs. Some common illnesses treated include skin infections, urinary tract infections, and respiratory diseases. Common antibiotics used in equine medicine include penicillin, gentamicin, and oxytetracycline to treat ailments such as pneumonia, skin infections, and regenerative anemia. It's crucial to administer the correct dosage to prevent microbial resistance. Antibiotics are vital for cattle health management. Tetracyclines and sulfonamides are frequently used for the prevention of bovine respiratory disease and mastitis. Misuse of antibiotics can lead to antimicrobial resistance and food-chain contamination. Frequent use of antibiotics in swine production, including lincomycin and chlortetracycline, is common for the prevention of diseases such as swine dysentery and pneumonia. It's essential to maintain the responsible use of antibiotics to ensure food safety. Enrofloxacin, amoxicillin, and doxycycline are typically used in poultry farming for the treatment and prevention of diseases such as avian cholera, infectious bronchitis and coccidiosis.

Regional Insights

In the Americas, the market for animal antibiotics & antimicrobials is driven by the significant presence of intensive animal farming practices and a growing emphasis on animal welfare. The rising demand for animal-derived products, coupled with increased awareness of disease prevention in livestock, contributes to the widespread use of antibiotics in the region. Advanced veterinary healthcare infrastructure and stringent regulations further shape the landscape, with North and South American countries actively contributing to the expansion of the animal antibiotics & antimicrobials market. In the Asia-Pacific region, the animal antibiotics & antimicrobials market experiences substantial growth due to the increasing demand for animal protein, particularly in countries including China and India. The expansion of the livestock industry, coupled with a rising focus on improving animal health and productivity, drives the adoption of antibiotics in the region. Within the EMEA region, the market for animal antibiotics & antimicrobials is influenced by stringent regulations on antibiotic use in livestock, particularly in European countries. The emphasis on sustainable farming practices and heightened concerns about antimicrobial resistance contribute to shaping the market dynamics. Additionally, the Middle East and Africa witness growth in animal farming activities, driven by increasing urbanization and dietary changes. The EMEA region plays a pivotal role in steering the global direction of responsible and effective use of animal antibiotics & antimicrobials.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibiotics & Antimicrobials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibiotics & Antimicrobials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibiotics & Antimicrobials Market, highlighting leading vendors and their innovative profiles. These include American Regent Inc., Ayurvet, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Inovet Group, Neogen Corporation, Norbrook Laboratories Ltd., Novartis AG, Phibro Animal Health Corporation, Sanofi-Aventis Groupe S.A., Tianjin Ringpu Biotechnology Co., Ltd., Vetoquinol S.A., Virbac S.A., Zoetis, Inc., and Zydus Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibiotics & Antimicrobials Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Antibiotics
- Antimicrobial

Mode of Delivery
- Injections
- Oral

Form
- Powders & Tablets
- Solutions

Type of Animal
- Companion Animals
  - Cats
  - Dogs
  - Horses

Food-Producing Animals
- Cattle
- Pigs
- Poultry
- Sheep & Goats

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Animal Antibiotics & Antimicrobials Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibiotics & Antimicrobials Market?

3. What are the technology trends and regulatory frameworks in the Animal Antibiotics & Antimicrobials Market?

4. What is the market share of the leading vendors in the Animal Antibiotics & Antimicrobials Market?

5. Which modes and strategic moves are suitable for entering the Animal Antibiotics & Antimicrobials Market?

Product Code: MRR-031BF22F949D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising demand for livestock products and strong demand for penicillin based antibiotics
  - 5.1.1.2. Increasing government involvement in countering animal diseases outbreaks
  - 5.1.1.3. Growing huge capital investment for the development of drugs for animal diseases
- 5.1.2. Restraints
  - 5.1.2.1. Concerns regarding resistance to antibiotic stringent regulatory approvals
- 5.1.3. Opportunities
  - 5.1.3.1. Accelerating advanced research and development facilities, and new drug development activities
  - 5.1.3.2. Growing focus towards sustainability of new antimicrobials
- 5.1.4. Challenges
  - 5.1.4.1. Availability of substitutes
5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing need for antibiotics for disease prevention and treatment
- 5.2.2. Mode of Delivery: Rising inclination towards oral administration as it's a non-invasive procedure
- 5.2.3. Form: Increasing usage of antimicrobial solutions for treating individual animals with severe bacterial infections
- 5.2.4. Type of Animal: Expanding need for antibiotics & antimicrobials among companion animals to manage bacterial infections
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Animal Antibiotics & Antimicrobials Market, by Product

6.1. Introduction
6.2. Antibiotics
6.3. Antimicrobial

7. Animal Antibiotics & Antimicrobials Market, by Mode of Delivery

7.1. Introduction
7.2. Injections
7.3. Oral

8. Animal Antibiotics & Antimicrobials Market, by Form

8.1. Introduction
8.2. Powders & Tablets
8.3. Solutions

9. Animal Antibiotics & Antimicrobials Market, by Type of Animal

9.1. Introduction
9.2. Companion Animals
9.3. Food-Producing Animals

10. Americas Animal Antibiotics & Antimicrobials Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Animal Antibiotics & Antimicrobials Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Animal Antibiotics & Antimicrobials Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Zoetis Demonstrates Canine Innovation with Commercial Launch of Librela (bedinvetmab injection) in the U.S.
- 13.3.2. Huvepharma Returns The Only FDA-Approved Triple-Sulfa Medication To US Market
- 13.3.3. Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio